Northland Capmk Forecasts Envoy Medical Q3 Earnings

Envoy Medical, Inc. (NASDAQ:COCH) – Northland Capmk issued their Q3 2025 earnings estimates for Envoy Medical in a note issued to investors on Wednesday, April 23rd. Northland Capmk analyst C. Byrnes anticipates that the company will post earnings of ($0.35) per share for the quarter. The consensus estimate for Envoy Medical’s current full-year earnings is ($1.21) per share. Northland Capmk also issued estimates for Envoy Medical’s Q4 2025 earnings at ($0.38) EPS, FY2025 earnings at ($1.41) EPS and FY2026 earnings at ($1.67) EPS.

Separately, Ascendiant Capital Markets raised their target price on Envoy Medical from $9.00 to $9.25 and gave the company a “buy” rating in a research note on Monday, April 21st.

Envoy Medical Trading Up 1.4 %

NASDAQ:COCH opened at $1.48 on Friday. The firm has a 50 day moving average of $1.38 and a 200-day moving average of $1.75. Envoy Medical has a 1 year low of $1.21 and a 1 year high of $5.42. The stock has a market capitalization of $31.56 million, a P/E ratio of -1.05 and a beta of 2.35.

Envoy Medical (NASDAQ:COCH) last released its quarterly earnings data on Friday, March 28th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.12). The business had revenue of $0.04 million during the quarter, compared to analysts’ expectations of $0.07 million.

Institutional Trading of Envoy Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Citadel Advisors LLC bought a new position in shares of Envoy Medical in the 4th quarter worth $42,000. CIBC Private Wealth Group LLC acquired a new stake in Envoy Medical during the 4th quarter worth $65,000. Lake Street Advisors Group LLC acquired a new stake in shares of Envoy Medical during the fourth quarter worth about $65,000. Finally, DSG Capital Advisors LLC acquired a new position in shares of Envoy Medical in the 4th quarter valued at approximately $234,000. 8.59% of the stock is owned by institutional investors.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.